These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15324486)

  • 21. A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test.
    Saruwatari J; Nakagawa K; Shindo J; Tajiri T; Fujieda M; Yamazaki H; Kamataki T; Ishizaki T
    Clin Pharmacol Ther; 2002 Aug; 72(2):200-8. PubMed ID: 12189367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man.
    Chen Y; Kang Z; Yan J; Yang GP; Tan ZR; Zhou G; Ouyang DS
    J Ethnopharmacol; 2010 Oct; 132(1):213-8. PubMed ID: 20723593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice.
    Kong LD; Yang C; Ge F; Wang HD; Guo YS
    J Ethnopharmacol; 2004 Aug; 93(2-3):325-30. PubMed ID: 15234772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
    Benowitz NL; Peng M; Jacob P
    Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.
    Rasmussen BB; Brøsen K
    Ther Drug Monit; 1996 Jun; 18(3):254-62. PubMed ID: 8738764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers.
    Pavanello S; Simioli P; Lupi S; Gregorio P; Clonfero E
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):998-1003. PubMed ID: 12376499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children.
    Kennedy MJ; Abdel-Rahman SM; Kashuba AD; Leeder JS
    J Clin Pharmacol; 2004 Jul; 44(7):708-14. PubMed ID: 15199075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effects of interleukin-10 on human cytochrome P450 activity.
    Gorski JC; Hall SD; Becker P; Affrime MB; Cutler DL; Haehner-Daniels B
    Clin Pharmacol Ther; 2000 Jan; 67(1):32-43. PubMed ID: 10668851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.
    Relling MV; Lin JS; Ayers GD; Evans WE
    Clin Pharmacol Ther; 1992 Dec; 52(6):643-58. PubMed ID: 1458773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity.
    Stillwell WG; Kidd LC; Wishnok JS; Tannenbaum SR; Sinha R
    Cancer Res; 1997 Aug; 57(16):3457-64. PubMed ID: 9270013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole weakly inhibits CYP1A2 activity in man.
    Rost KL; Fuhr U; Thomsen T; Zaigler M; Brockmöller J; Bohnemeier H; Roots I
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):567-74. PubMed ID: 10584979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caffeine metabolism in cystic fibrosis: enhanced xanthine oxidase activity.
    Hamelin BA; Xu K; Vallé F; Manseau L; Richer M; LeBel M
    Clin Pharmacol Ther; 1994 Nov; 56(5):521-9. PubMed ID: 7955816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females.
    Wenk M; Todesco L; Krähenbühl S
    Br J Clin Pharmacol; 2004 Apr; 57(4):495-9. PubMed ID: 15025748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of Saireito (TJ-114), a traditional Japanese herbal medicine, on postoperative edema and inflammation after total hip arthroplasty.
    Kishida Y; Miki H; Nishii T; Inoue T; Nishida S; Yoshikawa H; Sugano N
    Phytomedicine; 2007 Sep; 14(9):581-6. PubMed ID: 17292595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH; Nierenberg DW; Bresnick E
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail.
    Shelepova T; Nafziger AN; Victory J; Kashuba AD; Rowland E; Zhang Y; Sellers E; Kearns G; Leeder JS; Gaedigk A; Bertino JS
    J Clin Pharmacol; 2005 Dec; 45(12):1413-21. PubMed ID: 16291717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
    Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD
    Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Palo WA; Eustace D; Vernillet L; Joseph-Ridge N
    Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary effects of Sideritis scardica "mountain tea" on human in vivo activities of xenobiotic metabolizing enzymes in healthy subjects.
    Begas E; Kilindris T; Kouvaras E; Tsioutsioumi A; Kouretas D; Asprodini EK
    Food Chem Toxicol; 2018 Dec; 122():38-48. PubMed ID: 30266316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.